WallStreetZenWallStreetZen

AnalystsYasmeen Rahimi
Yasmeen Rahimi's Stock Forecasts

Analyst Ranking
Top 4%
#153 out of 4476 analysts
Average Return
+41.97%
Win Rate
48%31 out of 65
Risk vs Reward
Poor
Good

Yasmeen Rahimi's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Prometheus Biosciences IncRXDX
+681.50%$24.76$193.50
2022-06-09 -
2023-04-18
Strong Buy
89bio IncETNB
+495.95%$2.96$17.64
2022-05-17 -
2023-05-17
Strong Buy
Akouos IncAKUS
+346.13%$2.97$13.25
2022-05-17 -
2022-10-19
Strong Buy
Pliant Therapeutics IncPLRX
+344.83%$4.84$21.53
2022-05-17 -
2023-05-17
Strong Buy
Madrigal Pharmaceuticals IncMDGL
+311.28%$46.80$192.48
2017-10-18 -
2018-10-19
Strong Buy

Yasmeen Rahimi's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Anaptysbio IncANAB
1Strong Buy$80.00+209.24%Initiates Coverage On
8 days ago
Cymabay Therapeutics IncCBAY
4Hold$32.50+0.84%Downgrades
10 days ago
Soleno Therapeutics IncSLNO
1Strong Buy$93.00+89.80%Initiates Coverage On
19 days ago
Madrigal Pharmaceuticals IncMDGL
2Strong Buy$336.00+42.05%Maintains
a month ago
Newamsterdam Pharma Co NvNAMS
1Strong Buy$37.00+59.90%Initiates Coverage On
a month ago
Korro Bio IncKRRO
1Strong Buy$180.00+260.07%Initiates Coverage On
3 months ago
Structure Therapeutics IncGPCR
3Strong Buy$93.00+129.57%Maintains
4 months ago
Tourmaline Bio IncTRML
1Strong Buy$65.00+77.26%Initiates Coverage On
4 months ago
Immunovant IncIMVT
2Strong Buy$57.00+54.05%Maintains
4 months ago
Sagimet Biosciences IncSGMT
1Strong Buy$67.00+912.08%Initiates Coverage On
7 months ago
Protagonist Therapeutics IncPTGX
3Strong Buy$35.00+22.89%Reiterates
8 months ago
Acelyrin IncSLRN
1Strong Buy$68.00+817.68%Initiates Coverage On
9 months ago
Crinetics Pharmaceuticals IncCRNX
2Strong Buy$56.00+51.97%Initiates Coverage On
10 months ago
Prometheus Biosciences IncRXDX
3Hold$200.00+0.04%Downgrades
10 months ago
Allakos IncALLK
1Strong Buy$22.00+1,517.65%Initiates Coverage On
a year ago
Chinook Therapeutics IncKDNY
1Strong Buy$41.00+1.51%Initiates Coverage On
a year ago
Enanta Pharmaceuticals IncENTA
3Strong Buy$87.00N/AMaintains
a year ago
Prothena Corp Public Ltd CoPRTA
1Strong Buy$94.00N/AInitiates Coverage On
a year ago
Aligos Therapeutics IncALGS
4Strong Buy$7.00N/AMaintains
a year ago
Akouos IncAKUS
2Hold$13.00N/ADowngrades
a year ago
Verona Pharma PLCVRNA
1Strong Buy$31.00N/AInitiates Coverage On
a year ago
Cincor Pharma IncCINC
1Strong Buy$73.00N/AInitiates Coverage On
2 years ago
Lexicon Pharmaceuticals IncLXRX
1Strong Buy$10.00N/AInitiates Coverage On
2 years ago
Cytokinetics IncCYTK
2Strong Buy$72.00N/AMaintains
2 years ago
Praxis Precision Medicines IncPRAX
2Strong Buy$270.00N/AMaintains
2 years ago
Reneo Pharmaceuticals IncRPHM
2Strong Buy$18.00N/AMaintains
2 years ago
Pliant Therapeutics IncPLRX
1Strong Buy$27.00N/AMaintains
2 years ago
Immunic IncIMUX
2Strong Buy$39.00N/AMaintains
2 years ago
89bio IncETNB
2Strong Buy$19.00N/AMaintains
2 years ago
Altimmune IncALT
2Strong Buy$25.00N/AMaintains
2 years ago
Ventyx Biosciences IncVTYX
1Strong Buy$50.00N/AInitiates Coverage On
2 years ago
Tenaya Therapeutics IncTNYA
1Strong Buy$40.00N/AInitiates Coverage On
3 years ago
Vaxart IncVXRT
1Strong Buy$18.00N/AInitiates Coverage On
3 years ago
Liminal Biosciences IncLMNL
2Hold$45.00N/ADowngrades
3 years ago
Design Therapeutics IncDSGN
1Strong Buy$42.00N/AInitiates Coverage On
3 years ago
Savara IncSVRA
1Strong Buy$7.00N/AInitiates Coverage On
3 years ago
Albireo Pharma IncALBO
3Strong Buy$81.00N/AMaintains
3 years ago
Amarin Corp PLCAMRN
1Strong Buy$21.00N/AInitiates Coverage On
3 years ago
Arcturus Therapeutics Holdings IncARCT
1Strong Buy$77.00N/AInitiates Coverage On
3 years ago
Lumos Pharma IncLUMO
1Strong Buy$26.00N/AInitiates Coverage On
3 years ago
Ngm Biopharmaceuticals IncNGM
1Strong Buy$30.00N/AInitiates Coverage On
4 years ago
Mirum Pharmaceuticals IncMIRM
1Strong Buy$77.00N/AInitiates Coverage On
4 years ago
Axcella Health IncAXLA
1Strong Buy$625.00N/AInitiates Coverage On
4 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.